Jim Simons Renaissance Technologies
AUM
$75.2B
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+10.43%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$66.5B
AUM Growth
+$66.5B
(+13%)
Cap. Flow
+$3.3B
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
11.06%
Holding
4,024
New
580
Increased
1,552
Reduced
1,332
Closed
540
Top Buys
| 1 |
Microsoft
MSFT
|
$536M |
| 2 |
Apple
AAPL
|
$362M |
| 3 |
Micron Technology
MU
|
$270M |
| 4 |
Eli Lilly
LLY
|
$228M |
| 5 |
Cisco
CSCO
|
$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
$472M |
| 2 |
Tesla
TSLA
|
$463M |
| 3 |
NVIDIA
NVDA
|
$424M |
| 4 |
Coinbase
COIN
|
$236M |
| 5 |
Meta Platforms (Facebook)
META
|
$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Palantir
PLTR
$370B
| $1.43B | 2.15% | 38,419,240 -1,096,069 | -3% | -$40.8M |
|
2
Novo Nordisk
NVO
$250B
| $975M | 1.47% | 8,189,315 -976,059 | -11% | -$116M |
|
3
United Therapeutics
UTHR
$13.8B
| $772M | 1.16% | 2,155,392 -19,300 | -0.9% | -$6.92M |
|
|
4
Apple
AAPL
$3.46T
| $763M | 1.15% | 3,276,203 +1,554,759 | +90% | +$362M |
|
5
Vertex Pharmaceuticals
VRTX
$101B
| $759M | 1.14% | 1,631,493 +65,105 | +4% | +$30.3M |
|
|
6
Microsoft
MSFT
$3.77T
| $676M | 1.02% | 1,571,271 +1,246,346 | +384% | +$536M |
|
7
VeriSign
VRSN
$25.4B
| $603M | 0.91% | 3,175,990 +148,294 | +5% | +$28.2M |
|
8
Sprouts Farmers Market
SFM
$13.7B
| $490M | 0.74% | 4,440,644 +2,500 | +0.1% | +$276K |
|
9
Airbnb
ABNB
$79.6B
| $459M | 0.69% | 3,616,495 +215,090 | +6% | +$27.3M |
|
|
10
NVIDIA
NVDA
$4.26T
| $428M | 0.64% | 3,528,071 -3,493,719 | -50% | -$424M |
|
11
Exelixis
EXEL
$10.1B
| $399M | 0.6% | 15,359,916 +196,850 | +1% | +$5.11M |
|
12
Franco-Nevada
FNV
$35.9B
| $390M | 0.59% | 3,138,549 +64,600 | +2% | +$8.03M |
|
13
Cboe Global Markets
CBOE
$24.5B
| $385M | 0.58% | 1,879,724 +5,000 | +0.3% | +$1.02M |
|
14
Fortinet
FTNT
$60.5B
| $383M | 0.58% | 4,943,162 -83,232 | -2% | -$6.45M |
|
|
15
Meta Platforms (Facebook)
META
$1.86T
| $371M | 0.56% | 647,424 -398,709 | -38% | -$228M |
|
16
Gilead Sciences
GILD
$139B
| $351M | 0.53% | 4,188,524 -869,074 | -17% | -$72.9M |
|
17
Allison Transmission
ALSN
$7.31B
| $329M | 0.49% | 3,423,419 -99,100 | -3% | -$9.52M |
|
18
monday.com
MNDY
$9.89B
| $316M | 0.48% | 1,138,290 +15,600 | +1% | +$4.33M |
|
19
DoorDash
DASH
$104B
| $312M | 0.47% | 2,186,688 -601,155 | -22% | -$85.8M |
|
20
CME Group
CME
$95.9B
| $310M | 0.47% | 1,403,089 +784,500 | +127% | +$173M |
|
21
Corcept Therapeutics
CORT
$7.27B
| $301M | 0.45% | 6,509,002 -403,569 | -6% | -$18.7M |
|
22
Netflix
NFLX
$514B
| $298M | 0.45% | 420,209 +148,509 | +55% | +$105M |
|
23
Incyte
INCY
$16.3B
| $297M | 0.45% | 4,499,540 -718,797 | -14% | -$47.5M |
|
24
Neurocrine Biosciences
NBIX
$13.7B
| $297M | 0.45% | 2,574,546 +106,400 | +4% | +$12.3M |
|
25
Wingstop
WING
$9.06B
| $291M | 0.44% | 699,146 +96,156 | +16% | +$40M |
|